The 1990 Clean Air Act Amendments require that health risk from exposure to vinyl acetate be assessed. Vinyl acetate is a nasal carcinogen in rats, but not mice, and induces olfactory degeneration in both species. A biologically based approach to extrapolating risks of inhalation exposure from rats to humans was developed, which incorporates critical determinants of interspecies dosimetry. A physiologically based pharmacokinetic (PBPK) model describing uptake and metabolism of vinyl acetate in rat nose was validated against nasal deposition data collected at three airflow rates. The model was also validated against observations of metabolically derived acetaldehyde. Modifying the rat nose model to reflect human anatomy created a PBPK model of the human nose. Metabolic constants from both rats and humans specific for vinyl acetate and acetaldehyde metabolism enabled predictions of various olfactory tissue dosimeters related to the mode of action. Model predictions of these dosimeters in rats corresponded well with observations of vinyl acetate toxicity. Intracellular pH (pH i ) of olfactory epithelial cells was predicted to drop significantly at airborne exposure concentrations above the NOAEL of 50 ppm. Benchmark dose methods were used to estimate the ED 10 and LED 10 for olfactory degeneration, the precursor lesion thought to drive cellular proliferation and eventually tumor development at excess cellular acetaldehyde levels. A concentration ؋ time adjustment was applied to the benchmark dose values. Humanequivalent concentrations were calculated by using the human PBPK model to predict concentrations that yield similar cellular levels of acetic acid, acetaldehyde, and pH i . After the application of appropriate uncertainty factors, an ambient air value of 0.4 to 1.0 ppm was derived. The biologically based approach supports a workplace standard of 10 ppm.
Vinyl acetate is a synthetic organic ester with a wide range of uses. The 1990 Clean Air Act Amendments include vinyl acetate as one of the 189 hazardous air pollutants listed under Title III because it has been shown to be a respiratory tract toxicant in experimental species (Bogdanffy et al., 1994) . Vinyl acetate is not a reproductive or developmental toxin (Mebus et al., 1995; Hurtt et al., 1995) . The purpose of this research is to develop a biologically based approach to inhalation dose-response assessment as an alternative to the U.S. Environmental Protection Agency (EPA) default procedures (1997) .
Vinyl acetate induces nasal tumors in rats, but not mice, following long-term inhalation exposure (Bogdanffy et al., 1994) . All but one of the nasal tumors were observed only at the terminal sacrifice, indicating a late-life dependency of tumor formation. Non-neoplastic lesions of the nasal cavity were observed in both rats and mice. Degeneration of the olfactory epithelium was the sentinel response. Limited 2-stage growth modeling of the tumor incidence data supports a mechanism that is more reliant on cell growth dynamics than mutation rates (Bogdanffy et al., 1999b) . The nature of the tumors, i.e., low malignancy, low degree of local invasion, and appearance at a microscopic level late in the study argue against a process of direct multiple genetic alterations leading to highly aggressive cancer cells. The analysis suggests that nonlinear extrapolation strategies for assessing risk are most appropriate.
Mechanistic studies were conducted to test the hypothesis that both the genotoxicity and degenerative cytotoxic effects were related to carboxylesterase-mediated hydrolysis of vinyl acetate to acetaldehyde and acetic acid (Kuykendall et al., 1993) . These studies support the hypothesis that the cytotoxic and carcinogenic effects of vinyl acetate are related to the carboxylesterase-mediated formation of acetic acid, a strong cytotoxicant, and acetaldehyde, a clastogen. In vitro and in vivo studies on both vinyl acetate and acetaldehyde suggest that neither induces point mutations although both are clastogenic in vitro (Brams et al., 1987; Lijinski and Andrews, 1980; Mäki-Paakkanen and Norppa, 1987; Owen, 1980a,b; ) . Research on the stability of acetaldehyde-induced DNA-protein crosslinks (DPXL) show that the crosslink is unstable at physiological temperature and pH (t 1/2 Х 6.5 h). This instability raises the possibility that the carcinogenic effect of vinyl acetate is less dependent on acetaldehyde-induced DPXL and more dependent on acetic acid-induced cytotoxicity (Kuykendall et al., 1992) . Furthermore, research on the effects of pH on clastogenic activity in vitro show that low pH alone can induce clastogenic responses similar to those induced by vinyl acetate (Morita, 1995; Morita et al., 1990; Sipi et al., 1992) . Therefore, conditions under which intracellular pH is maintained in a physiological range, such that cytotoxicity-induced cell proliferation is prevented, will likely minimize any potential contribution of acetaldehyde to the formation of DPXL. This research, in toto, suggests that acceptable human exposure levels will be those that are predicted to have no consequential effect on intracellular pH.
Cell proliferation studies showed a rebound response of olfactory epithelium to extended vinyl acetate exposure (1 day vs. 5 days, vs. 20 days) . These results suggest that restorative cell proliferation within the basal cell compartment, to replace lost sustentacular cells, becomes a driving event for neoplastic growth. Thus, in olfactory epithelium the carcinogenic response to vinyl acetate exposure appears to be driven largely by a cytotoxic, proliferative mechanism. The strength of the data, therefore, supports a mode of action that is most appropriately assessed using methods of analysis that account for nonlinear behavior in both tumor response and non-neoplastic lesion development.
Determinants of uptake and nasal-tissue dose were evaluated extensively including quantitative estimation of kinetic constants governing carboxylesterase and aldehyde dehydrogenase activities and histochemical localization of their cellular distributions (Bogdanffy et al., 1986 (Bogdanffy et al., , 1987 (Bogdanffy et al., , 1998 Bogdanffy and Taylor, 1993; Casanova-Schmitz et al., 1984) . Experiments utilizing a unique in vitro whole tissue gas uptake system demonstrated that vinyl acetate is almost completely metabolized in the most superficial layer of olfactory epithelium (sustentacular cells). Therefore, sustentacular cells are likely the primary target of vinyl acetate-induced olfactory toxicity, as has been shown for other esters (Trela and Bogdanffy, 1992) . Also of importance is the observation from the histochemical analyses that basal cells of olfactory epithelium, which are stem cells for proliferative regeneration and presumably are progenitor cells for neoplastic growth, are devoid of carboxylesterase activity (Bogdanffy et al., 1986) .
The kinetic constants were used in a physiologically based pharmacokinetic (PB-PK) model of the nasal cavity describing vinyl-acetate vapor extraction and metabolism, and acetic acidinduced changes in intracellular pH (pH i ) in the rat (Plowchalk et al., 1997) . The model adequately described vapor extraction data when a second carboxylesterase-removal term was included. This pathway is believed to represent high affinity carboxylesterase in the luminal plasma membrane (Bogdanffy et al., 1999a) . Dosimeters generated from the modeling showed a pattern that is consistent with the overall mechanistic hypothesis. The pH i of olfactory epithelium was predicted to drop at exposure concentrations Ͼ50 ppm, consistent with observations from the 2-year inhalation bioassay that found olfactory degeneration occurring at concentrations above 50 ppm. Therefore, dosimeters that are related to pH i (total amount of acetic acid formed and final proton concentration in olfactory tissue) appear to be the most tenable measures of tissue-dose, on mechanistic grounds.
The mechanistic approach to dose-response assessment presented here, which integrates cancer and noncancer evaluations, is based on the hypothesis that olfactory degeneration is the initial cellular response to vinyl-acetate exposures. Cellular degeneration is believed to be induced when pH i drops to a critical level within the sustentacular cell. Subsequent sequential responses triggered by continued exposure include restorative cellular proliferation, basal cell hyperplasia, and, eventually, neoplasia. The general process used in this assessment is presented in Figure 1 . The PB-PK model presented here is an extension of the Plowchalk et al. (1997) model, in that (1) air phase resistance to mass transport in the nasal cavity is addressed, (2) the rat model is modified to account specifically for the dorsal anterior patch of olfactory epithelium that is the primary site of olfactory lesions, and (3) a model for the human nasal cavity is presented. The results presented focus on dosimetry to the olfactory compartment, since it is the site of greatest sensitivity to inhaled vinyl acetate.
tized by ip injection (63 mg/kg) of sodium pentobarbital and a nasopharyngeal cannula fitted with a septum-sealed T-junction was inserted to the level of the nasopharynx. Warm, humidified, vinyl acetate-laden air was drawn through the nasal cavity at flow rates of 50, 100, or 200 mL/min. Concentrations of vinyl acetate and acetaldehyde in the chamber air and air exiting the nasopharynx were measured over a 30-min period using gas chromatography.
Two hundred L air samples were drawn at approximately 5-min intervals with a gas-tight syringe from the chamber or the T-junction, and injected into a gas chromatograph (GC). The GC (a Hewlett Packard 58900) was equipped with a NON-PAKD 0.54 m id ϫ 10 M column, with an AT-1000 film (thickness of 1.2 m) (Alltech, Deerfield, IL). Gas chromatography conditions were as follows: injector temperature, 150°C; oven temperature, 40°C, isothermic; flame ionization detector temperature, 200°C; and carrier gas, helium at 3.8 ml/min. Concentrations were determined by comparison against gas-bag standards that were prepared daily. Acetaldehyde and vinyl acetate had retention times of approximately 1.3 and 1.7 min, respectively.
Statistical analysis of nasal extraction data. Nasal deposition data were compared by analysis of variance. Individual group differences were compared by Student's t test. Significance was judged at the p Ͻ 0.05 level.
Physiologically based modeling of vinyl acetate uptake and metabolism in rat/humans. Inhaled chemicals are extracted in the nasal cavity where they are then metabolized and absorbed into the systemic circulation. Numerous models have been developed to capture this interaction and predict the continuous variation in the concentration of the chemical species, both in the lumen air phase and the surrounding tissue. Early, whole-lung models used analytical methods to solve a convection-diffusion type equation, using appropriate boundary conditions, to predict the transport and absorption of the chemicals in the lung. These models assumed simple airflow patterns in the lumen and approximated the surrounding tissue as a homogenous medium. However, the nasal mucosa consists of a variety of cell types, each having a different metabolic activity toward the inhaled chemical. Furthermore, inspired air follows distinct paths in the nasal cavity, resulting in asymmetric ventilation to various regions (Kimbell et al. 1993) . Attempting a closed-form solution for the extraction of a highly metabolized chemical such as vinyl acetate, in a complex system such as the nasal cavity, becomes futile. A compartmental approach using PB-PK modeling has proved to be an effective alternative for predicting the extraction of highly soluble and reactive volatiles in the nasal cavity Morris et al., 1993; Plowchalk et al., 1997) . Plowchalk et al. (1997) , using a 3-compartment model similar to the one proposed by Morris et al. (1993) , described the uptake and metabolism of vinyl acetate in the rat nasal cavity. Computational flow models identify 2 distinct airflow pathways in the nasal cavities of both rats and humans: a lateral/ventral path and a dorsal/medial path (Kimbell et al., 1993) . Anatomically, the dorsal side has a small anterior patch of respiratory mucosa followed by a large patch of olfactory mucosa, and the ventral side is composed primarily of respiratory mucosa. The 3-compartment model, following this natural division, approximates the nasal mucosa by a respiratory compartment followed by an olfactory compartment along the dorsal air stream and a third respiratory compartment along the ventral air stream. To represent the mucus layer and the various cell types in the tissue, each of the 3 tissue compartments are further subdivided into a number of sub-compartments.
As stated earlier, vinyl acetate exposure induces non-neoplastic lesions in the rat nasal cavity, with degeneration of the olfactory epithelium as the critical response. In vivo experiments show that the severity of olfactory epithelial lesions decreases along an anterior-posterior gradient. Theoretically, by dividing the olfactory region into numerous compartments in the axial direction, a better approximation can be made of the proximal to distal scrubbing of the chemical from the inspired air stream and thereby achieve a better accounting of the distribution of the lesions observed in the nasal cavity. However, increasing the number of compartments in the model also makes the model computationally intense. Hence, a balance must be achieved between model complexity and model accuracy. To accurately capture the flux to the sensitive regions of the nasal mucosa that are at a higher risk of tissue damage due to vinyl acetate, a higher degree of compartmentalization of the nasal cavity is needed.
Here, we have extended the work of Plowchalk et al. (1997) by constructing
FIG. 1.
General approach to utilizing the PB-PK model in deriving human-equivalent exposure concentration.
a 5-compartment model of the rat nasal cavity and a 4-compartment model of the human nasal cavity. To better characterize the vinyl acetate flux to the apical regions of the olfactory compartments, the 5-compartment rat model divides the olfactory region into 2 compartments, a small dorsal anterior compartment and a larger posterior compartment (Fig. 2) . The respiratory mucosa on the ventral side is also divided into an anterior and a posterior compartment, resulting in 5 tissue compartments, similar to the model structure proposed by Bush et al. (1998) . Since the human nasal cavity has only a small area covered with olfactory mucosa, we use just one olfactory compartment along the dorsal air stream in the equivalent human PB-PK model. The specific parameters used in the model are presented in Table 1 . The current model also incorporates air phase resistance to mass transfer from the lumen to the air:mucus interface (Fig. 3) . This is an improvement over the previous model by Plowchalk et al. (1997) that assumes equilibrium between the air and the mucus phase. The set of mass balance equations modeling the transport of vinyl acetate and its metabolic products across the lumen, mucus, and tissue sub-compartments are described in the appendix. Vinyl acetate extraction in the nasal cavity is a function of both the geometry of the nasal cavity and enzyme activity in the lining tissue. A detailed quantitative estimate of the various cell layer thicknesses comprising the olfactory and the respiratory mucosa of the rat and the human is provided by Bogdanffy et al. (1998) . These quantitative estimates are used in our model. Nasal carboxylesterase and aldehyde dehydrogenase are critical enzymes in the mechanism of metabolic activation and detoxification of vinyl acetate. These enzymes are located in specific cell and tissue types within the nasal cavity. The extent to which vinyl acetate is extracted from the air stream and metabolized is dependent upon the complement of enzyme activity in the various tissue sub-compartments. Carboxylesterase activity is histochemically detectable in all epithelial cells and seromucus glands of respiratory mucosa (Bogdanffy et al., 1987) . In olfactory mucosa, carboxylesterase is present in sustentacular cells and Bowman's glands. Aldehyde dehydrogenase is present in all epithelial cells of respiratory mucosa, but is present in only the basal cells and Bowman's glands of the olfactory mucosa (Bogdanffy et al., 1986) . Distribution of enzymes to specific compartments in each tissue stack was based on histochemical localization and is described in detail by Plowchalk et al. (1997) . Enzyme kinetic constants for carboxylesterase and aldehyde dehydrogenase were obtained from a whole tissue, in vitro, gas uptake technique (Bogdanffy et al., 1998) . Liver acetyl-CoA synthetase kinetic constants were taken from the literature and assumed to be the same for nasal tissue (Knowles et al., 1974) . Vmax values for each compartment were scaled based on tissue surface areas. Data collected from the in vivo vapor deposition experiments were used to calibrate the model.
Benchmark dose modeling.
The 10% response level and the associated 95th percent lower confidence limit (ED 10 and LED 10 , respectively) were chosen as the benchmark response metrics, or points of departure, for interspecies dosimetry extrapolation and low-dose risk extrapolation. The ED 10 and LED 10 values were determined from the fit of the Log-logistic and Weibull models to various nasal-lesion data sets. Guidance on implementing benchmark dose evaluations suggests that different model structures be fit to the data (U.S. EPA, 1995) . The choice of models should consider statistical goodnessof-fit parameters as well as model structure, although it is recognized that these models are not biologically motivated and are used primarily to interpolate the dose-response function within the range of the experimental data. Choice of the model for derivation of the dose-response estimate was then based on consideration of those models with adequate goodness-of-fit to the data.
The Weibull model is defined as follows:
where c is the nonzero background rate of response, d is the exposure concentration (or other dose metric), d 0 is an estimated intercept dose, and ␤ and ␥ are estimated parameters. The fit of the Weibull model was accomplished using the THRESHW computer software (ICF Kaiser International, Ruston, LA). The Weibull model can be fit either with or without the estimation of a statistical threshold. The no-threshold form of the Weibull model was evaluated because of concern within the risk assessment community over the meaning of the statistical threshold that can be calculated. Nevertheless, the mechanism proposed (cytotoxicity under conditions of reduced pH i ) is expected to exhibit dose-response characteristics that are highly nonlinear. The
FIG. 2.
Schematic of the PB-PK 5-compartment model of the rat nasal cavity used to compute vinyl-acetate extraction and acetaldehyde exhalation under steady-state conditions. The general structure of the human model is identical to that of the rat, with the exception of having only one olfactory tissue compartment. 44.6 CE V max , olfactory high affinity pathway (mg/hr) Gross et al., 1982; DeSesso, 1993 c Uses values for rat from Morris et al. (1993) scaled to species based on cardiac output and nasal region based on surface area. Total nasal perfusion, estimated to be 0.3% cardiac output compares favorably with measured values (Stott, 1983) .
d Kimbell et al., 1993; Subramaniam et al., 1998; Hahn et al., 1993 e Frederick et al., 1998 f Frederick et al, 1998 ; 100 mL/min values used for rat, and 11.4 and 18.9 L/min values for humans. g Optimized, scaled to humans based on surface area h Optimized i Measured (Bogdanffy et al., 1998) j Knowles et al., 1974 , scaled to humans base on surface area k Estimated l Goldsmith and Hilton (1992) analyst also has the option of restricting the limits on ␥ . All Weibull analyses were performed with this parameter restricted. Values of ␥ less than 1 would imply a supralinear dose-response which is not consistent with the proposed mode of action.
The Log-logistic model is often used, particularly where dose-response data are highly nonlinear, and is defined as:
This model is recommended by the U.S. EPA for fitting dichotomous data and has gained wide support as a model useful for fitting a variety of dose-response behaviors and deriving risk-associated exposure values by interpolation (Barnes et al., 1995) . The fit of the Log-logistic model was accomplished using the BIOASSAY software (Hasselbaud, Inc.). The Loglogistic model was run with a restriction on ␤ to be greater than one, as was done with the Weibull model. In some cases, the model was run with no restriction on ␤.
The ED 10 and LED 10 values generated from these analyses were then converted to human-equivalent values through the intermediate step of estimating tissue dosimetrics from the PB-PK model discussed above (Fig. 1) .
RESULTS

Nasal Extraction Experiment
Extraction of vinyl acetate from the nasal air stream and release of acetaldehyde into the air stream were nonlinear with exposure concentration (Fig. 4) . Increasing nasal airflow rate from 50 to 200 mL/min caused a flow-dependent decrease in vinyl acetate extraction but did not have an effect on acetaldehyde release into the air stream (p Ͻ 0.05).
Physiologically Based Modeling
Model simulations of the nasal extraction studies are shown in Figure 4 . To optimize the high affinity carboxylesterase Vmax and Km, iterative simulations of the model were conducted with the inspiratory flow rate set at 100 mL/min and the resulting simultaneous predictions of nasal extraction and acetaldehyde release compared to the observations. The best fit yielded a Vmax and Km for the high-affinity pathway of 1.3 mg/h and 4.7 ϫ 10 -3 mg/mL, respectively. These values were used in subsequent simulations at airflow rates of 50 mL/min and 200 mL/min in rats. With one exception, the simulations presented in Figure 4 show an adequate prediction of both extraction of vinyl acetate from, and release of acetaldehyde into the air exiting the nasal cavity at both the 50 mL/min and 200 mL/min flow rates. A systematic over-prediction of expired acetaldehyde was noted at the highest vinyl acetate concentrations as airflow rate decreased.
Dosimeters predicted for olfactory epithelium (olfactory-1 compartment) of rats, at exposure levels simulating the bioassay conditions, are presented in Tables 2 and 3 . Results for respiratory compartments (not shown) were similar to that reported previously (Plowchalk et al., 1997) . In olfactory-1 of rats, most metabolite dosimeters are predicted to be approximately proportional to inhaled concentration up to 200 ppm (Table 2) . At 600 ppm, however, 7-to 19-fold increases were observed with a 12-fold increase in exposure concentration. Those dosimeters with greater than a 12-fold predicted increase include vinyl acetate steady state tissue concentration and acetaldehyde and acetic acid amounts formed per mL tissue. Predictions for human olfactory tissue were similar in trend, although nonlinearity appeared at 200 ppm with increases as high as 68-fold evident at 600 ppm (e.g., acetic acid steadystate tissue concentration).
Predictions of olfactory acidification are presented in Table  3 . For both rat and humans, pH i is predicted to drop most significantly at exposure concentrations above 50 ppm. The change in pH i is predicted to be slightly greater for human olfactory epithelium, than that of rats, per ppm inhaled vinyl acetate.
Sensitivity Analysis
The importance of the various parameters to model predictions were evaluated by changing the parameter and observing the change in the output function of interest. Representative sets of sensitivity coefficients (SC) are provided in Table 4 . These SC are derived for the rat at 200 and 600 ppm (0.703 and 2.11 g/mL, respectively) for free H ϩ -ion concentration at the end of 0.4-h exposures in the rat, where the nasal tissues were calculated to be at steady state. SC values varied between the 2 concentrations, indicative of nonlinear behaviors. The largest SCs (Ͻ0.05) were observed for parameters associated with olfactory epithelial tissue volumes (i.e., epithelial depth) and surface areas, the proton antiport system (kinetic parameters and Hill coefficient), the high affinity esterase pathway, and apportionment of flow to the dorsal airstreams.
Benchmark Dose Evaluations
Benchmark dose evaluations for the range of potential responses is presented in Table 5 . Non-neoplastic responses provided the lowest 10% response estimates with the ED 10 values in the range of approximately 47 to 59 ppm. The Log-logistic model provided the best visual and statistical fit to the data, although the p values for the non-neoplastic responses were generally less than 0.01 (Fig. 5) . P values for the fit of the Log-logistic model to the tumor responses were greater than 0.96. The Weibull model consistently over-predicted a response at 50 ppm for data sets in Table 5 and gave p values smaller than the Log-logistic model (not shown). Therefore, based on visual fit of the model to the response data and statistical considerations, the dose-response model chosen for derivation of the benchmark estimates was the Log-logistic model. Olfactory precursor lesions were chosen as the response endpoint to carry forward through the dose-response assessment, since it represents the most complete characterization of the elements of the proposed mode of action that were evaluated in the 2-year bioassay.
Concentration/Duration Adjustments
Following estimation of the ED 10 and LED 10 , a determination is made regarding the need to adjust these exposure values to reflect the anticipated human exposure scenario. The rats in the 2-year inhalation bioassay were exposed to vinyl acetate vapor for periods of 6 h per day, 5 days per week. As this is a typical workplace-exposure regimen, no adjustment needs to be made for purposes of establishing an acceptable workplaceexposure value. The human exposure scenario anticipated under ambient conditions is 24 h per day, 7 days per week. A conventional default concentration/duration (C ϫ t) adjustment is carried out by multiplying the ED 10 and LED 10 values by the product (6/24 ϫ 5/7), or 0.18.
The default adjustment may or may not be appropriate for a given toxic mode of action. For example, irritants typically display concentration/duration profiles in which toxicity is   FIG. 4 . Model simulations vs. experimental observations of nasal extraction of vinyl acetate and acetaldehyde release into expired air during the nasal extraction studies. Nasal extraction studies were carried out at three flow rates. The studies conducted at a flow rate of 100 mL/min were used to optimize the high affinity/low capacity metabolic pathway used in the whole nose model. Model simulations of the experiment (open circles) were run for each exposure concentration and flow rate. Experimental observations (filled squares) are the mean Ϯ SE for n ϭ 4 or 5.
more dependent on exposure concentration than on duration. For other toxic agents, cumulative exposure to toxic metabolites is the primary determinant of toxicity and expression of toxicity follows C ϫ t relationships.
To examine the need for a C ϫ t correction, it is important to discuss the kinetics of pH reduction versus the time course of the sentinel nasal lesion, olfactory degeneration. Model predictions of intracellular pH reduction during a 6-h inhalation exposure of rats to vinyl acetate show that pH stabilizes within the first 0.1 h (predicted kinetic profiles in humans are nearly identical) (Plowchalk et al., 1997) . Thus, for extended duration exposures, one would not predict a strong dependency of toxic outcome on duration of exposure. Indeed, olfactory degeneration is not dependent on duration of exposure, for at least up to 20 exposures . On the other hand, when the vinylacetate exposure duration is extended to 2 years, dependency of response on exposure duration becomes apparent. For example, olfactory degeneration is not observed in rats exposed to 200 ppm vinyl acetate for 6 h/day, 5 days/week for 4 weeks. Olfactory degeneration is observed (67% incidence) when rats are similarly exposed for 2 years. Thus there appears to be a relationship between exposure duration and response that becomes apparent only after chronic exposure, thereby supporting the need for a C ϫ t adjustment to the ED 10 and LED 10 . The C ϫ t-corrected ED 10 and LED 10 values are presented in Table 6 .
Interspecies Dosimetry Extrapolation
Using the rat PB-PK model and conducting simulations of a 6-h exposure under a resting ventilation rate of 197 mL/min, the benchmark dose-derived external exposure concentrations were converted to their respective predicted tissue amounts of acetic acid and acetaldehyde and final intracellular pH of the olfactory-1 compartment (Table 6 ). Thus, the amount of acetic acid predicted to be formed in rat olfactory-1 tissue at the LED 10 ADJ of 8.7 ppm is 0.84 mg. Next, the human PB-PK model was run to estimate the external exposure concentration necessary to produce the pH i changes shown in Table 6 . These modeling results are presented in Table 7 . Thus, the LED 10 ADJ of 8.7 ppm in the rat (from Table 6 ) is estimated to be equivalent to 10.0 ppm in the human. A worker exposure scenario was evaluated using the LED 10 (not duration adjusted) and a light exercise breathing rate of 20 L/min. The human-equivalent exposure concentration is estimated to be 19.2 ppm (Table 8) . Note. Values are for the olfactory-1 compartment of rats and the single olfactory compartment for humans. Simulations were run at an inspiratory flow rate of 197 mL/min for rats or 7.5 L/min for humans.
DISCUSSION
Recent advances in guidelines for assessing risk of exposure to carcinogens via the inhalation route include the revised carcinogen risk-assessment guidelines and the methods for derivation of inhalation reference concentrations (RfC) (U.S. EPA, 1994) . Both guidelines support the use of biologically based approaches when data are sufficient to supplant default approaches. The carcinogen risk-assessment guidelines in particular stress developing an understanding of mode of action to guide choice of possible methods of low-dose extrapolation; linear and nonlinear. A nonlinear default is considered when there is no evidence to support linearity and when the mechanistic data support an assumption of nonlinearity for the carcinogenic mode of action (U.S. EPA, 1996) .
Despite the weak genotoxic activity of vinyl acetate, its mode of carcinogenic action at low doses is expected to be highly nonlinear. Dose-response curves are, in fact, nonlinear in the region of experimental observation (Bogdanffy et al., 1994) . Vinyl acetate induces chromosomal aberrations in mammalian cells whereas in vitro assays for point mutations are negative (IARC, 1995 for review). A similar pattern of genotoxic activity is observed for acetaldehyde, which is derived metabolically from vinyl acetate (Dellarco, 1988) . Thus, the clastogenic activity of both compounds is likely due to their ability to form DPXL (Kuykendall and Bogdanffy, 1992; 1994; Lam et al., 1986) . Because the process of converting DPXL to mutations involves multiple complex steps such as DNA breakage, translocation, and reannealing of sequences, the entire process is expected to be highly nonlinear (Rhomberg et al., 1990) . Additional processes contributing to the expression of cancer that appear to be nonlinear include pharmacokinetic processes (e.g., metabolic detoxicification of acetaldehyde and processes controlling cellular acidification) (Plowchalk et al., 1997) and cytotoxicity-induced cell proliferation .
The RfC methodology provides a default approach to addressing many of the pharmacokinetic factors that contribute to interspecies differences in dosimetry of inhaled substances. The methodology also provides a framework for replacing many of the defaults with chemical-specific experimental data (Bogdanffy and Jarabek, 1995) . The PB-PK models presented here for the rat and human improve upon the default method by adjusting interspecies differences in dosimetry, based on mode of action. The PB-PK model accounts for various uncertainties related to interspecies extrapolation. Some of the more important interspecies differences to be considered include air phase mass-transfer characteristics, rates of metabolism and production of toxic metabolites, and compartmental segregation of respiratory and olfactory tissues. Furthermore, unlike default approaches, the model is calibrated and validated against vinyl acetate-specific dosimetry data.
Our approach to incorporating PBPK-based dosimetry conversions is consistent with the RfC approach. That is, human equivalent-tissue dose estimates are derived from the NOAEL identified in animal studies. The NOAEL in this assessment was established by benchmark dose procedures (i.e., the ED 10 and LED 10 ) but was not substantially different from the study NOAEL (e.g. 56.5/43.9 ppm for the ED 10 /LED 10 vs. 50-ppm NOAEL). This approach is different from using the PBPK model to convert the rat external-exposure concentrations to tissue dose equivalents and then using the tissue exposure estimates as dose inputs to the BMD modeling. For vinyl acetate, it makes no material difference if the PBPK adjustment is done before or after the BMD analysis, since the tissue dosimeters are linearly related to external exposure concentration in the region of the ED 10 /LED10 (see below). This may not be the case for other chemicals.
At high concentrations, vinyl acetate extraction from the rat nasal cavity was nonlinear. This observation was also made by Plowchalk et al. (1997) , who validated an earlier version of the rat nasal model against an entirely separate data set. Nonlinear extraction behavior has been seen with other inhaled vapors such as acetaldehyde (Morris, 1997; Morris and Blanchard, 1992) and acrylic esters (Morris and Frederick, 1995) , although the degree of nonlinearity is pronounced for vinyl acetate. Extraction in the low-concentration region appears to be governed by a high affinity/low capacity esterase located in the luminal surface of the epithelium (Bogdanffy et al., 1999a) . That nasal extraction of vinyl acetate was dependent on nasal airflow rate also suggests a metabolism-dependent extraction process that is flow-limited.
Nonlinear behaviors were also observed in the model predictions of several dosimeters. Although most dosimeters increased proportionately with vinyl acetate-exposure concentration from 50 ppm to 200 ppm, disproportionate increases were predicted at the 600-ppm exposure level. In particular, steady state and AUC levels of vinyl acetate in humans were predicted to increase more than 60-fold at the high exposure concentration compared to a 12-fold change in exposure concentration. However, because parent vinyl acetate is not likely to be the toxic species critical to the mode of action, it is more appropriate to consider tissue levels of the metabolites acetaldehyde and acetic acid. When expressed as amount (mg) formed per mL of tissue, and compared to the 50 ppm exposure level, both acetaldehyde and acetic acid levels are predicted to rise disproportionately in the olfactory tissue of rats (17-fold) and humans (48-fold) exposed to 600 ppm vinyl acetate. These observations are consistent with the non-linear increase in tumor incidence observed in rats exposed to vinyl acetate at 600 ppm (Bogdanffy et al., 1994) . Intracellular acidification is the proposed mechanism of tissue cytotoxicity. Significant reductions in pH i were predicted at 200 ppm. These predictions are consistent with the sharp rise in incidence of olfactory degeneration noted among rats exposed to 200 ppm vinyl acetate (Bogdanffy et al., 1994) . The sensitivity analysis revealed several important features of the model. The model predictions were quite sensitive to nasal anatomy and airflow patterns; however, these parameters are fairly well understood. The high affinity mucus pathway is known by its role in extraction in vivo and the identification of a high affinity carboxylesterase in isolated rat nasal mucus (Bogdanffy et al., 1999a) . In humans, however, this pathway is inferred to be present. Another important determinant is the antiport system. The characteristics of the Na ϩ /H ϩ pump in nasal tissues are not known at this time although the values used in the model are derived from human tissues (leucocytes). Experimentation to define these important parameters could further reduce uncertainties currently inherent in this and other upper-airway dosimetry models.
Application of Uncertainty Factors to Derive Ambient Airand Workplace-Exposure Standards
The composite uncertainty factor for the existing vinyl acetate RfC is 30 (U.S. EPA, 1997) . This factor is composed of a factor of 10 to account for variability in dosimetry and response within the human population, and a factor of 3 that remains after application of the default dosimetry adjustment factor (DAF r ). Remaining uncertainty factors addressing subchronic-to-chronic extrapolation, LOAEL-to-NOAEL extrapolation, or addressing an incomplete data set in the existing RfC are already set at 1. Since the mechanistic approach is based on a sentinel lesion and uses PB-PK modeling for interspecies dosimetry extrapolation, adjustments to the default assumption can be considered. Support for potential adjustments to the residual uncertainty factor of 30 that address interspecies and intraspecies uncertainty for the alternative approach is discussed below.
The standard default value used to account for each of the factors involved with (1) variability within the human population, and (2) interspecies extrapolation uncertainty, is 10 for each. Each factor of 10 can be parceled into 2 factors of 3 that account for "pharmacokinetic" and "pharmacodynamic" uncer-
FIG. 5.
Fit of the Log-logistic model to the precursor lesion data set. Panels A and B are similar, except that the x axis in panel B has been broken to highlight the proximity of the maximum likelihood fit to the NOAEL of 50 ppm and its relationship to the lower confidence limit (LED 10 ). tainties in response (Jarabek, 1995) . Interspecies extrapolation uncertainty will be discussed first.
The interspecies factor is applied to address the uncertainty in extrapolating from valid results of long-term studies on experimental animals to the average human, when results of human exposure are not available or are inadequate. The pharmacokinetic portion of this factor is already reduced to 1 in the default approaches, because the default RfC methodology attempts to address some of the uncertainty in uptake and disposition through the default dosimetric adjustment known as DAF r (Jarabek, 1995) . The interspecies dosimetry model developed for vinyl acetate is an improvement over the default DAF . The model makes use of specific data on vinyl acetate deposition and metabolism (pharmacokinetics), the latter in both rats and humans, and incorporates specific data on mechanism of action (pharmacodynamics) that support the underpinnings of the dosimetry model. Consequently, the model extends the measure of internal dose in terms of tissue acetic acid amount and proton concentration, which are more closely associated with the pharmacodynamic responses of cytotoxicity and cellular proliferation. Pharmacodynamic aspects of the mechanism of toxicity are described in the pH submodel in which biological buffers and the Na ϩ /H ϩ antiport enable predictions of pH i , thereby establishing a biologically based link between dosimetry and tissue response. In addition, presenting the cellular acidification predictions in terms of pH i provides an expression that is less abstract and that biologists/risk assessors can readily associate with cellular toxicity. The mechanism-based approach provides more rigorous estimations of rat and human pharmacokinetics/pharmacodynamics and thus supports a reduction of the remaining uncertainty factor of 3 to a factor of 1.
The uncertainty factor accounting for variability within the human population will be discussed next. The first parcel of 3 in this factor represents the within-humans variability of pharmacokinetic factors controlling response. An example of this might be subpopulations with especially high nasal carboxylesterase activities, since metabolism is an essential determinant of vinyl acetate uptake and disposition. The second factor of 3 accounts for variability in pharmacodynamic factors within the human population that control response. An example of this might be subpopulations whose nasal epithelium is especially sensitive to changes in intracellular pH, perhaps because of pre-existing disease.
With regard to the "pharmacokinetic" portion of the intraspecies factor (value of 3), data illustrating variability within the human population, of the critical factors controlling dosimetry, impact this value. Since variability within the workplace population is expected to be minimal relative to the general population, this parcel of 3 would not be appropriate if deriving a workplace-exposure standard. As shown by the sensitivity analysis, the PB-PK model is highly sensitive to choice of airflow rates, kinetic constants controlling the carboxylesterase-mediated metabolism of vinyl acetate to acetic acid, and the kinetic constants controlling the Na ϩ /H ϩ antiport. Sectors of the human population with variants of these factors that increase their sensitivity should be accounted for in this factor.
The values chosen in the human PB-PK model for airflow rate (7.5 and 20 L/min) represent breathing conditions of a healthy adult during average conditions or mild exercise, re- Note. Simulations conducted using an inspiratory flow rate of 197 mL/min and gas phase mass transfer coefficients for 100 mL/min. a ADJ indicates that a C ϫ t multiplier of 0.18 has been applied to the ED10 or LED10 value. Note. Simulations conducted using an inspiratory flow rate of 7.5 L/min and gas phase mass transfer coefficients for 11.4 L/min.
a ADJ indicates that a C ϫ t multiplier of 0.18 has been applied to the ED10 or LED10 value.
spectively. The 20-L/min value is widely accepted as a standard value representative of workplace exposures. We would not expect to find sectors of the human population who have airflow rates during mild exercise that differ significantly from this value. Although it is possible for transient exposures of the general population to occur under conditions of exercise, the likelihood of this situation occurring continuously over a lifetime seems remote.
Regarding the human kinetic constants controlling vinyl acetate hydrolysis, there appears to be a fair degree of homogeneity of rates of vinyl acetate metabolism by the tissues measured using the in vitro gas uptake technique (Bogdanffy et al., 1998) . It could be argued, therefore, that there has been at least a partial accounting for some of the uncertainty related to variations in carboxylesterase activity within the human population. Again, this is unlikely to be a source of uncertainty for workplace populations, given their generally healthy status and the observation that carboxylesterase activities are similar among adults. However, it is unknown if potentially sensitive sectors exist in the general population (such as children) that possess unusually high nasal carboxylesterase activity. The sample population used to derive the human kinetic constants does not appear to be diverse enough to shed light on this uncertainty. Furthermore, the human kinetic constants derived from the in vitro gas uptake technique appear to represent the low-affinity carboxylesterase pathway. As discussed above, the high-affinity pathway governs metabolic conversion of vinyl acetate to acetic acid at low exposures. For this pathway, the value estimated for rats, obtained from optimization routines, was adopted for humans and was scaled to account for differences in tissue amount between rats and humans. Therefore, there has been only a minimal accounting for intra-human variability with regard to the pathways of carboxylesterase metabolism.
The kinetic constants controlling the Na ϩ /H ϩ antiport were from data obtained on human leukocytes. Parameters controlling the antiport include V max , K H , and the Hill coefficient, all of which vary between tissue types (Frelin et al., 1988) . For example, excitable cells control pH i in a more alkaline range due to a high K H relative to renal cells. Thus, tissue-to-tissue variability in antiport parameters suggests that the lack of data on these constants for human nasal tissue is a source of uncertainty. Therefore, although there has been a partial accounting for this "pharmacokinetic" factor using data derived from human tissue, there is insufficient data to make a reasonably full accounting of the variability within the general human population with regard to antiport activity.
With regard to pre-existing disease states within the general human population that could exacerbate tissue responses to vinyl acetate exposure, there is little information available. In fact, there are few diseases known to be pre-existent and not attributable to some source of ambient exposure. Effects such as rhinitis, rhinorrhea, irritation, and other swelling of the mucus membranes are shared among those caused by airborne allergens and low-level chemical exposure (Leopold, 1995) .
In conclusion, the composite uncertainty factor that is recommended for deriving an ambient exposure limit is 10. The parcels of 3 remaining are those that account for pharmacokinetic and pharmacodynamic aspects of intraspecies extrapolation. Residual uncertainties that comprise this factor of 10 could be reduced through additional research. Such research might include (1) experimental assessment of rat and human nasal epithelial cell Na ϩ /H ϩ antiport activities, and (2) more extensive assessment of variability within the human population in carboxylesterase activities, especially with regard to the high affinity pathway. Applying this factor of 10 to the humanequivalent concentration (LED 10 ADJ ) for inhalation rates reflective of average physical activity (10 ppm) yields a recommended ambient exposure limit of 1.0 ppm. The analogous value derived for conditions of lifetime light exercise is thus 0.4 ppm and would represent an extreme lower bound.
Concerning a workplace standard, the human-equivalent concentration of 19 ppm is approximately 2-fold above the value of 10 ppm currently supported by various industrial hygiene standards (e.g., American Conference of Governmental Industrial Hygienists (ACGIH) value of 10 ppm, 8-h, timeweighted average, 15 ppm ceiling (ACGIH, 1997); German MAK value of 10 ppm (Deutsche Forschungsgemeinschaft, 1997)). A value of 20 ppm is therefore considered an upper limit for workplace exposures. Figure 3 shows the schematic of the lumen and the surrounding mucus and tissue layers in the nasal cavity. Inhaled vinyl acetate is absorbed in the nasal cavity at the air:mucus interface and then diffuses into the tissue, wherein it is metabolized and finally removed by blood perfusion. In our model, air in the lumen is assumed to be a homogenous medium and the underlying mucus-tissue-submucosal tissue layers are assumed to be Note. Simulations conducted using an inspiratory flow rate of 20 L/min and gas phase mass transfer coefficients for 18.9 L/min.
APPENDIX
another continuously homogenous medium, separated from the bulk air by the air:mucus interface. The convection-diffusion equation describes the mass transport of the chemical species (Rehsenow and Choi, 1961) in both the air phase (lumen) and the liquid phase (mucus and tissue):
Here C is the concentration of the chemical species in g/ml, U is the bulk fluid velocity in cm/s, D is the diffusivity of the chemical in cm 2 /s, and l is the chemical loss per unit control volume in g/ml Ϫ s. The first two terms on the left hand side of the above equation denote the rate of change of concentration of the chemical species in the control volume and the mass transport due to convection (bulk fluid motion), respectively. The next 2 terms on the right hand side represent the mass transport due to diffusion, and the loss term, respectively. In the lumen, this loss is due to convective mass transport from the air phase to the air:mucus interface. In the tissue, this loss term is due to metabolic activity and (or) blood flow.
Equation 1 is a differential representation for the mass transport in a homogenous medium in terms of continuous concentration gradients. As elaborated in the main text, our model is a compartmental description. Here the lumen (air phase) is represented by a single compartment and the surrounding mucus and tissue stacks are represented by multiple sub-compartments. The concentration of the chemical species in these various sub-compartments is approximated by a finite set of mixed mean concentrations. In this section, we discuss simplifications to the governing differential equation for mass transport and the finite difference techniques used to discretize the governing differential equations to a set of algebraic equations in terms of the mixed mean concentrations.
Air Phase Compartment
The Peclet number (Pe ϭ Ud/D), which is a ratio of the convective to diffusive mass transport, is approximately equal to 100 in the nasal cavity (Sarangapani and Wexler, 1996) . This implies that convection is the dominant mode of transport for the chemical in the air compartment (lumen). Hence, the diffusion term in Equation 1 can be neglected. Assuming steady state, the governing differential equation for chemical transport in the lumen reduces to: U(ѨC/Ѩx) ϭ Ϫl. Using a first order finite difference approximation for ѨC/Ѩx, the above equation transforms as (Press et al., 1992) :
where C in is the chemical concentration at the inlet to the air compartment, C out is the outlet concentration, and ⌬X is a measure of the axial dimension of the air compartment. Multiplying both sides by the volume of the air compartment we get: Q(C in Ϫ C out ) ϭ L, where Q is the fluid flow rate in the lumen in ml/s and L is the total loss of the chemical from the air compartment to the air:mucus interface. Assuming wellmixed conditions in the air compartment, this loss term can be obtained as a product of the interfacial surface area (SA), mass transport coefficient (k g ), and the concentration gradients between the bulk air and the interface (C out Ϫ C gi ). Plugging this into Equation 2a results in:
Liquid Phase Compartments
In the mucus and tissue sub-compartments bulk fluid motion is absent. Hence, the convective term in Equation 1 can be neglected. Under steady state, the governing differential equation for chemical transport in the mucus and tissue sub-compartments reduces to: Ѩ 2 C/Ѩx 2 ϭ l. Using a second order finite difference approximation for Ѩ 2 C/Ѩx 2 , the above equation transforms as (Press et al., 1992) :
where C jϪ1 , C j and C jϩ1 are the mixed mean concentration in three consecutive liquid phase sub-compartments and "w" is the width of these compartments. Multiplying both sides of the above equation by the compartment volume and explicitly expressing the loss term due to metabolic activity and blood perfusion, we get:
where v j , K j are the Michaelis-Menten kinetic parameters in g/s and g/ml, respectively, in the j th compartment and Q j b is the rate of blood perfusion in ml/s for this compartment. The above equation is a restatement of the mass balance in the j th compartment, showing that the difference in mass flux coming in and going out of the j th compartment is equal to the loss by metabolic activity and blood perfusion. If the liquid phase is divided into N sub-compartments, Equation 3b is valid for all the interior compartments (i.e., j ϭ 2 to j ϭ N Ϫ 1). To completely solve for all the N concentration variables, appropriate boundary conditions need to be applied at the air:mucus interface (j ϭ 1) and in the blood exchange region (j ϭ N).
Mass balance at the air:mucus interface implies that the flux into the liquid layer is equal to the flux from the air phase. Hence, the differential representation for the boundary condition at the air:mucus interface is:
Discretizing ѨC/Ѩx in the above equation, using first order finite difference method, and expressing the interfacial gas phase concentration in terms of the interfacial liquid-phase concentration and Henry's constant between air and mucus, we get:
A common engineering practice (U. S. EPA, 1994) while expressing the net flux across the boundary is to represent the above equation in terms of a composite mass transport coefficient, K.
where, 1/K ϭ 1/k g ϩ w/2D. Similarly, mass balance in the last compartment (j ϭ N) states that the flux into the Nth compartment should equal the clearance due blood perfusion in this compartment. Expressing this mathematically, we have:
Discretizing ѨC/Ѩx in the above equation using first order finite difference method, we get:
This results in a set of N ϩ 1 algebraic equations (Equations 2b, 3b, 4b, 5b) :
These need to be solved simultaneously to determine the mixed mean concentration of the chemical species in the N ϩ 1 sub-compartments. If more than one chemical species is involved, a similar set of mass-balance equations may be derived for each chemical species. This physiologically based pharmacokinetic model was constructed with ASCL for windows (Mitchell and Gauthier Associates, Concord, MA). The code will be made available upon request.
